Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1994 1
1995 4
1996 6
1997 1
1998 1
1999 1
2001 3
2002 3
2003 2
2004 1
2005 1
2006 5
2007 4
2008 5
2009 2
2010 8
2011 5
2012 4
2013 7
2014 5
2015 1
2016 2
2017 1
2018 4
2019 1
2020 1
2021 2
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, Gac AC, Bonnet C, Bouabdallah K, Feugier P, Specht L, Molina L, Touati M, Borel C, Stamatoullas A, Nicolas-Virelizier E, Pascal L, Lugtenburg P, Di Renzo N, Vander Borght T, Traverse-Glehen A, Dartigues P, Hutchings M, Versari A, Meignan M, Federico M, André M; LYSA-FIL-EORTC Intergroup. Fornecker LM, et al. Among authors: vander borght t. J Clin Oncol. 2023 Jan 10;41(2):327-335. doi: 10.1200/JCO.21.01281. Epub 2022 Jul 22. J Clin Oncol. 2023. PMID: 35867960 Free article. Clinical Trial.
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.
Wauthier L, Favresse J, Hardy M, Douxfils J, Le Gal G, Roy PM, van Es N, Ay C, Ten Cate H, Vander Borght T, Dupont MV, Lecompte T, Lippi G, Mullier F. Wauthier L, et al. Among authors: vander borght t. Diagnostics (Basel). 2022 Nov 12;12(11):2770. doi: 10.3390/diagnostics12112770. Diagnostics (Basel). 2022. PMID: 36428830 Free PMC article. Review.
Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.
Berriolo-Riedinger A, Becker S, Casasnovas O, Vander Borght T, Édeline V. Berriolo-Riedinger A, et al. Among authors: vander borght t. Cancer Radiother. 2018 Sep;22(5):393-400. doi: 10.1016/j.canrad.2018.06.001. Epub 2018 Jul 20. Cancer Radiother. 2018. PMID: 30033076 Review.
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.
Stamatoullas A, Ghesquières H, Feugier P, André M, Le Bras F, Gac AC, Borel C, Gastinne T, Quittet P, Morschhauser F, Ribrag V, Guidez S, Nicolas-Virelizier E, Berriolo-Riedinger A, Vander Borght T, Edeline V, Brice P. Stamatoullas A, et al. Among authors: vander borght t. Leuk Lymphoma. 2022 Dec;63(13):3063-3071. doi: 10.1080/10428194.2022.2107204. Epub 2022 Aug 17. Leuk Lymphoma. 2022. PMID: 35975738 Clinical Trial.
Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient data.
Leroy S, Romanello C, Galetto-Lacour A, Bouissou F, Fernandez-Lopez A, Smolkin V, Gurgoze MK, Bressan S, Karavanaki K, Tuerlinckx D, Leblond P, Pecile P, Coulais Y, Cubells C, Halevy R, Aygun AD, Da Dalt L, Stefanidis CJ, Vander Borght T, Bigot S, Dubos F, Gervaix A, Chalumeau M. Leroy S, et al. Among authors: vander borght t. J Pediatr. 2011 Oct;159(4):644-51.e4. doi: 10.1016/j.jpeds.2011.03.008. Epub 2011 Apr 20. J Pediatr. 2011. PMID: 21511275 Review.
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.
Oprea-Lager DE, Gontier E, García-Cañamaque L, Gauthé M, Olivier P, Mitjavila M, Tamayo P, Robin P, García Vicente AM, Bouyeure AC, Bailliez A, Rodríguez-Fernández A, Mahmoud SB, Vallejo-Casas JA, Maksud P, Merlin C, Blanc-Durand P, Drouet C, Tissot H, Vierasu I, Vander Borght T, Boos E, Chossat F, Hodolic M, Rousseau C. Oprea-Lager DE, et al. Among authors: vander borght t. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3439-3451. doi: 10.1007/s00259-023-06301-5. Epub 2023 Jun 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 37341747 Free PMC article. Clinical Trial.
81 results